Search results for "Virology"

showing 10 items of 2354 documents

Decrease in HDV endemicity in Italy.

1997

To evaluate a possible variation in hepatitis D virus endemicity in Italy, the data from a multicentre study concerning HBsAg chronic carriers first observed in 31 liver units during 1992 were compared with the corresponding figures from a similar study performed in 1987.In both studies the methodology for the recruitment of cases was the same. The overall anti-HD prevalence in 1992 was 14.4%, a significantly lower rate than that observed in 1987 (23.4%, p0.01). The decrease significantly (p0.01) affected both males and females; it occurred in all geographical areas, although to a greater extent in northern regions. It was evident in subjects below 50 years of age, but not in subjects older…

AdultMaleHBsAgmedicine.medical_specialtyCirrhosisAdolescentEndemic DiseasesVirusRisk FactorsEpidemiologymedicinePrevalenceHumansChildHepatitis B Surface AntigensHepatologyHepatitis D virus infectionbusiness.industryClinical Laboratory TechniquesIncidence (epidemiology)Infant NewbornInfantMiddle Agedmedicine.diseaseVirologyHepatitis DItalyChild PreschoolCarrier StateFemaleViral diseaseHepatitis D virusbusinessJournal of hepatology
researchProduct

Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients

2016

International audience; In hepatitis B “e” antigen (HBeAg) positive patients with hepatitis B virus (HBV) mono-infection, intensification of nucleos(t)ide analogue treatment with pegylated interferon (PegIFN) could help induce higher HBeAg seroclearance rates. Our aim was to determine the long-term effect of adding PegIFN to tenofovir (TDF)-containing antiretroviral therapy on seroclearance in HBeAg-positive patients co-infected with the human immunodeficiency virus (HIV) and HBV. In this prospective matched cohort study, 46 patients with 1-year PegIFN intensification during TDF-containing antiretroviral therapy (TDF+PegIFN) were matched 1:1 to controls undergoing TDF without PegIFN (TDF) u…

AdultMaleHBsAgmedicine.medical_specialtyCirrhosisTenofovirmedicine.disease_causeAntiviral Agents[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyGastroenterology03 medical and health sciencesHepatitis B Chronic0302 clinical medicinePegylated interferonVirologyInternal medicinemedicineHumansHepatitis B e AntigensLongitudinal StudiesProspective Studies030212 general & internal medicineTenofovirProspective cohort studyHepatitis B virusHepatologybusiness.industryvirus diseasesMiddle AgedHepatitis Bmedicine.diseasedigestive system diseases3. Good healthTreatment OutcomeInfectious DiseasesHBeAgImmunology[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemale030211 gastroenterology & hepatologyInterferonsbusinessmedicine.drug
researchProduct

Serological pattern of Hepatitis B, C, and HIV infections among immigrants in Sicily: epidemiological aspects and implication on public health.

2011

The objective of this study was to describe the prevalence of Hepatitis B virus (HBV), Hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections in a cohort of immigrants living in Palermo, Sicily. The study was carried out in the period May 2006-June 2010 and recruited a total of 393 patients (59.8% males-median age of 32.6 years). All patients were tested for serological markers of HBV, HCV, and HIV infection. One-hundred thirty-eight (35.1%) individuals did not show any HBV/HCV/HIV serological marker, while 186 (47.3%) were indicative of past or current HBV infection. A total of 42 (10.7%) subjects were HBsAg positive, 59 (15.0%) showed the serological profile "anti-HBc …

AdultMaleHBsAgmedicine.medical_specialtyHealth (social science)HIV AntigensHepatitis C virusEmigrants and ImmigrantsHIV InfectionsSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeEpidemiologymedicinePrevalenceHumansHuman immunodeficiencySicilyRetrospective StudiesHepatitis B virusHepatitis B Surface Antigensbusiness.industryPublic healthPublic Health Environmental and Occupational Healthvirus diseasesHepatitis CHepatitis BMiddle Agedmedicine.diseaseHepatitis BVirologyHepatitis B Core AntigensHepatitis Cdigestive system diseasesCross-Sectional StudiesCohortFemalePublic HealthHepatitis C AntigensbusinessBiomarkersImmigrantJournal of community health
researchProduct

Familiar clustering and spreading of hepatitis delta virus infection

1985

The prevalence of hepatitis delta virus (HDV) infection was significantly higher among the relatives of 79 carriers of HBsAg with antibody to HDV (index cases) than among relatives of 111 carriers without serological evidence of HDV infection (controls). Antibody to HDV was found in 45 of the 80 (56%) carriers of HBsAg in families of index cases but only in 2 of 59 (3%) carriers in families of controls (P less than 0.0001). During follow-up new HDV infection developed in 31% of 13 susceptible carriers in families of index cases, but only in 1.2% of 162 susceptible carriers in families of controls (P less than 0.001). None of the family members previously unexposed to the hepatitis B virus h…

AdultMaleHBsAgvirusesmedicine.disease_causeVirusmedicineHumansHepatitis B virusHepatologybiologyInfantvirus diseasesbiochemical phenomena metabolism and nutritionHepatitis BHepatitis Bmedicine.diseaseHepatitis DVirologyHepatitis DChild PreschoolCarrier StateImmunologybiology.proteinFemaleViral diseaseAntibodyViral hepatitisFollow-Up Studies
researchProduct

DOUBLE DEMONSTRATION OF ONCOGENIC HIGH RISK HUMAN PAPILLOMA VIRUS DNA AND HPV-E7 PROTEIN IN ORAL CANCERS

2011

Oncogenic HPVs are necessarily involved in cervical cancer but their role in oral carcinogenesis is debated. To detect HPV in oral cancer, 38 cases of formalin fixed-paraffin embedded OSCC were studied by both DNA genotyping (MY09/11 L1 consensus primers in combination with GP5-GP6 primer pair followed by sequencing) and immunohistochemistry (monoclonal Abs against capsid protein and HPV-E7 protein, K1H8 DAKO and clone 8C9 INVITROGEN, respectively). HPV-16 tonsil cancer was used as positive control. The overall prevalence of HPV infection in OSCCs was 10.5%. Amplification of DNA samples showed single HPV DNA infection in 3 cases (HPV16; HPV53; HPV70) and double infection in one case of chee…

AdultMaleHPVPapillomavirus E7 ProteinsImmunologyBiologymedicine.disease_causeVirusoral carcinogenesisSettore MED/28 - Malattie Odontostomatologicheoncogenic proteinsmedicineImmunology and AllergyHumansGenotypingPapillomaviridaeAgedNeoplasm StagingPharmacologyCervical cancerAged 80 and overE-7Papillomavirus InfectionsHPV infectionCancervirus diseasesMiddle Agedmedicine.diseaseHPV oral cancerVirologyfemale genital diseases and pregnancy complicationsstomatognathic diseasesCancer cellDNA ViralCarcinoma Squamous CellE-7; HPV; oncogenic proteins; oral carcinogenesis; OSCC;FemaleMouth NeoplasmsOSCCPrimer (molecular biology)Carcinogenesis
researchProduct

HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated…

2003

Abstract Background/Aims HVR-1 quasispecies composition and evolution were investigated in patients chronically infected with genotype 1b HCV, treated with PEG-IFN α2b or STD-IFN α2b plus RBV. Methods HVR-1 heterogeneity was assessed by calculating nucleotidic complexity, diversity, synonymous (S) and non-synonymous (NS) substitutions at baseline, after 4 weeks of therapy ( T 1) and at follow-up ( T 18). Evolution of viral quasispecies was analysed by constructing phylogenetic trees. Results No correlation of baseline viremia with heterogeneity was observed. Nucleotidic complexity was lower in patients showing early virological response, and tended to be inversely correlated to viral load d…

AdultMaleHepacivirusHepatitis C virusViremiaHepacivirusViral quasispeciesInterferon alpha-2medicine.disease_causeAntiviral AgentsVirusPolyethylene GlycolsEvolution MolecularViral Proteinschemistry.chemical_compoundFlaviviridaeDrug Resistance ViralRibavirinmedicineHumansPhylogenyHepatologybiologyRibavirinGenetic VariationInterferon-alphaHepatitis C ChronicMiddle AgedPrognosisbiology.organism_classificationmedicine.diseaseVirologyRecombinant ProteinschemistryImmunologyDrug Therapy CombinationFemaleViral loadHCV Interferon Quasispecies HVR-1
researchProduct

HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-α

1995

Recently, it was demonstrated in chronic hepatitis C that the release of IgG and IgM anti-HCV antibodies by mononuclear cells (PBMCs) correlated with inflammatory activity, HCV persistence in serum, and negative outcome from antiviral therapy. Thus, persistent antigenic stimulation of the antibody-secreting B cells has been suggested. In this study, PBMCs were derived from 13 patients with chronic hepatitis C. Nucleic acids were extracted by the guanidine-thiocyanate-method, and plus- and minus-stranded HCV-RNAs were determined using primers from the 5'-untranslated region of HCV. Simultaneously, unstimulated PBMCs were cultured for 8 days and anti-HCV antibodies were detected in the supern…

AdultMaleHepacivirusmedicine.medical_treatmentHepatitis C virusMolecular Sequence DataAlpha interferonHepacivirusInterferon alpha-2Virus Replicationmedicine.disease_causeAntiviral AgentsPeripheral blood mononuclear cellVirusVirologymedicineHumansCells CulturedInterferon alfaAgedDNA PrimersB-LymphocytesBase SequencebiologyInterferon-alphavirus diseasesHepatitis C AntibodiesMiddle Agedbiology.organism_classificationHepatitis CVirologyRecombinant Proteinsdigestive system diseasesTreatment OutcomeInfectious DiseasesCytokineChronic DiseaseImmunologyLeukocytes Mononuclearbiology.proteinRNA ViralFemaleAntibodymedicine.drugJournal of Medical Virology
researchProduct

Lack of hepatitis B virus DNA sequences in sera from patients with acute and chronic liver diseases diagnosed as non-A, non-B-hepatitis

2008

— The sera of 15 individuals with transfusion-associated acute or chronic non A, non B hepatitis, which lacked hepatitis B virus markers, were tested for hepatitis B virus DNA by dot blot hybridization test. Three sera of two patients positive in this test, however, also gave positive results when the labeled plasmid was used as probe instead of labeled HBV-DNA, indicating false positive results in the initial test. In conclusion, the data indicated that sera of patients with confirmed non A, non B hepatitis do not contain DNA-sequences in the serum hybridizing with HBV-DNA.

AdultMaleHepatitis B virusAdolescentHepatitis Viral HumanDot blotmedicine.disease_causeChronic liver diseaseVirusPlasmidmedicineHumansFalse Positive ReactionsAgedHepatitis B virusHepatologybiologybusiness.industryMiddle AgedHepatitis Bmedicine.diseasebiology.organism_classificationHepatitis CVirologyHepadnaviridaeDNA ViralImmunologyFemaleViral diseasebusinessLiver
researchProduct

Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive…

1992

The hepatitis D virus (HDV) infection plays a major role in severe liver damage caused by hepatitis. To establish the prevalence of HDV infection in haemophilic patients and patients without haemophilia, 87 patients with chronic hepatitis B virus (HBV) infection were examined for serological evidence of delta hepatitis. In addition HBV, HDV and human immunodeficiency virus type 1 (HIV) infection markers were compared to clinical and histopathological outcome of hepatitis. Out of 46 haemophiliacs 30 (65%) were anti-HD-seropositive; 10 out of 30 anti-HD-positive patients (33%) had pathological liver function tests compared to 2 out of 16 anti-HD-negative haemophiliacs (13%). The rate of HIV i…

AdultMaleHepatitis B virusCirrhosisAdolescentvirusesBiopsyRadioimmunoassaymedicine.disease_causeHaemophiliaHemophilia AmedicineHumansHepatitis AntibodiesHepatitis B e AntigensChildAntigens ViralHepatitis ChronicHepatitis B virusHepatitisAcquired Immunodeficiency SyndromeHepatitis B Surface Antigensbiologymedicine.diagnostic_testbusiness.industryvirus diseasesMiddle Agedmedicine.diseasebiology.organism_classificationHepatitis BVirologyHepatitis DHepatitis DHepadnaviridaeLiverLiver biopsyChild PreschoolPediatrics Perinatology and Child HealthDNA ViralHepatitis D virusHepatitis Delta VirusbusinessEuropean journal of pediatrics
researchProduct

Hepatitis B and C virus variants in long-term immunosuppressed renal transplant patients in Latvia.

2004

The incidence of genome variants of hepatitis B and hepatitis C viruses among 38 long-term (2–15 years) immunosuppressed patients after renal transplantation and 10 patients undergoing dialysis was investigated. Twelve patients had only HBV infection, 9 had only HCV infection and 14 were co-infected. Regions corresponding to the HBV X/EnII/BCP, preC/C, preS/S and to the HCV core were sequenced for molecular characterization of the HBV and HCV genomes. Fifty-seven percent of HBV DNA isolates belonged to genotype D and 42% to genotype A, whereas 77% of HCV RNA isolates belonged to genotype 1b and only 17% to genotype 3a. One sample (6%) was of genotype 2c. Detailed analysis of the above-menti…

AdultMaleHepatitis B virusGenes ViralGenotypeHepatitis B virus DNA polymerasemedicine.medical_treatmentSequence HomologyHepacivirusVirusHepatitis B virus PRE betaVirologymedicineImmune ToleranceHumansPoint MutationDialysisPhylogenyAgedbusiness.industryIncidence (epidemiology)Hepatitis CHepatitis BMiddle Agedmedicine.diseaseHepatitis BVirologyHepatitis CKidney TransplantationLatviaTransplantationInfectious DiseasesAmino Acid SubstitutionFemalebusinessSequence AnalysisIntervirology
researchProduct